JONATHAN MOONEY: Open Payments
NPI 1427603935 · PEORIA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,660 in 133 payments from 10 companies in 2025. Trend: 2023 $1,343 · 2024 $1,687 · 2025 $3,660
Food & beverage: $3,648Education: $12
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 26 | $617 |
| Alkermes, Inc. | 9 | $508 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $407 |
| Otsuka America Pharmaceutical, Inc. | 15 | $372 |
| ABBVIE INC. | 15 | $364 |
| Neurocrine BioSciences, Inc. | 18 | $359 |
| E.R. Squibb & Sons, L.L.C. | 12 | $317 |
| Vanda Pharmaceuticals Inc. | 10 | $277 |
| Janssen Pharmaceuticals, Inc | 10 | $261 |
| Axsome Therapeutics, Inc. | 4 | $179 |
Products named: AUSTEDO XR, CAPLYTA, VRAYLAR, INGREZZA, COBENFY, FANAPT, INVEGA SUSTENNA, ARISTADA.
Industry payments across IL — which companies pay providers there.
